MACMIC(SH:688711)2025-04-28 09:10Financial Performance - The company's operating revenue for Q1 2025 was CNY 297,430,509.01, representing a 20.70% increase compared to CNY 246,424,021.52 in the same period last year[4] - The net profit attributable to shareholders was CNY 1,083,674.81, a significant recovery from a loss of CNY 1,716,177.99 in the previous year[4] - Total operating revenue for Q1 2025 reached ¥297,430,509.01, an increase of 20.7% compared to ¥246,424,021.52 in Q1 2024[19] - Net profit for Q1 2025 was ¥94,306.57, a significant improvement from a net loss of ¥3,105,871.88 in Q1 2024[20] - The company reported a gross profit margin of approximately 1.3% for Q1 2025, compared to a negative margin in Q1 2024[20] - Basic and diluted earnings per share for Q1 2025 were both ¥0.0051, recovering from a loss of ¥0.0081 per share in Q1 2024[21] Cash Flow and Liquidity - The net cash flow from operating activities decreased by 44.92% to CNY 21,524,419.01, down from CNY 39,078,925.17 due to increased payments to employees and taxes[7] - The company's cash flow from operating activities for Q1 2025 is yet to be detailed, but it is a critical area for future reporting[22] - Cash inflow from operating activities totaled $236,420,086.91, a decrease of 3.1% compared to $244,807,507.93 in the previous period[23] - The company reported a net cash and cash equivalents decrease of $64,033,818.42, compared to a decrease of $3,867,150.15 in the prior period[24] - The ending balance of cash and cash equivalents was $130,216,495.42, down from $184,355,906.33 at the end of the previous period[24] Assets and Liabilities - Total assets at the end of the reporting period were CNY 2,566,403,656.56, a decrease of 1.35% from CNY 2,601,502,300.71 at the end of the previous year[5] - The company reported a decrease in equity attributable to shareholders, which was CNY 1,069,961,771.15, down 0.53% from CNY 1,075,637,627.91 at the end of the previous year[5] - Total liabilities decreased to ¥1,487,691,335.85 from ¥1,523,923,995.00, indicating improved financial stability[18] Research and Development - Research and development expenses totaled CNY 26,099,911.79, accounting for 8.78% of operating revenue, down from 10.47% in the previous year[5] - The company has ongoing investments in research and development, with R&D expenses amounting to ¥26,099,911.79 in Q1 2025, slightly up from ¥25,807,674.59 in Q1 2024[20] Shareholder Actions - The company approved a share repurchase plan with a total amount not less than RMB 25 million and not exceeding RMB 50 million, with a maximum repurchase price of RMB 30.12 per share[12] - The company has repurchased a total of 922,983 shares, accounting for 0.4336% of the total share capital, with a total payment of RMB 16,379,066.02[13] Strategic Focus - The company is focused on enhancing its product development and technological advancements to drive future growth[12] - The company is focusing on market expansion and new product development as part of its strategic initiatives moving forward[22]